Apheresis variability control in cell therapy manufacturing

Reduce variability in cell therapy manufacturing with standardized, automated management of apheresis product and process control strategies for mononuclear cell enrichment.

Secure the cell therapy supply chain from bench to bedside

The cryogenic supply chain of cell therapies presents challenges to the delivery of cell samples. Find out about approaches to help mitigate these risks.

Security of supply in cell and gene therapy manufacturing

Building an adequate supply chain with the necessary equipment and protocols is critical for companies pursuing cell and gene therapies. Learn about our security of supply program.